Please select your view
Dr Sudha Pottumarthy-Boddu comes to us from Houston, Texas, where she was Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Texas, School of Medicine. She was also the Technical Director of the Clinical Laboratory Services at the Houston Department of Health and Human Services.
After graduating from medical school in India, Dr Pottumarthy-Boddu migrated to New Zealand and completed her Pathology/Microbiology Fellowship training with the Royal College of Pathologists of Australasia. She is a recipient of various awards and scholarships, including the Neil Prentice Memorial Prize of RCPA. She is also a Diplomate of the American Board of Medical Microbiology.
Over the last 10 years she gained experience in various hospital, research, and public health laboratories in the US, publishing over 30 articles in peer-reviewed journals and presenting at various national and international conferences. Detection of the first USA isolate of Enterobacter spp., with NmcA carbapenem hydrolyzing enzyme and establishing clinical significance of Nocardia verterana are noteworthy. Dr Pottumarthy-Boddu’s main research interests are antimicrobial susceptibility trends and molecular methods in the diagnosis of infectious diseases.
Dr Linda Dreyer completed her undergraduate studies in 1996, receiving a Bachelor’s degree in Medicine and Surgery (MBChB) from the Faculty of Health Sciences, University of Pretoria, South Africa. Following four years of clinical practice, as Medical Officer in the Department of Family Medicine she commenced specialisation in 2000.
She was appointed as Registrar in Clinical Virology at the University of Pretoria/ Gauteng Province, where she worked for two years, and in 2003 she was appointed as Senior Registrar in Microbiology. Dr Dreyer received her Master’s degree in Clinical Microbiology (MMed (Path)) from the University of Pretoria in 2006. She worked as a consultant for the National Health Laboratory Services (NHLS) in Pretoria until January 2008. During her time at NHLS she was involved in teaching medical students and microbiology registrars and gave lectures to nursing staff, medical students, and specialists. She also sat on the Infection Control Committee and the Antimicrobial Stewardship Committee of the Pretoria Academic Hospital.
She came to Melbourne and joined Australian Clinical Labs (formerly Healthscope Pathology) in 2008 as a Senior Registrar and obtained Fellowship of The Royal College of Pathologists of Australasia (FRCPA) in 2010. Dr Dreyer has special interests in the appropriate use of antimicrobials, infection control, and molecular diagnostic assays in contemporary clinical microbiology.
Associate Professor Chris Barnes is the National Director of Haematology and provides strategic direction nationally for haematology at Clinical Labs. He is a clinical and laboratory trained haematologist who has been part of Melbourne Haematology and has worked with Clinical Labs (and previously Healthscope) for several years. A/Prof Barnes also works at the Royal Children’s Hospital and is director of the Haemophilia Treatment Centre. He has experience in both management and leadership positions. A/Prof Barnes has an active clinical research interest and is also director of Melbourne Haematology (Clinical) and Melbourne Paediatric Specialists.
Associate Professor Harris is Clinical Director of Microbiology at Australian Clinical Labs. He graduated in Medicine from Monash University in 1971 and completed his training at Geelong Hospital, obtaining FRCPA in 1982. Associate Professor Harris worked in general pathology at Geelong Pathology followed by PathCare as Consulting Pathologist. For the past 20 years, he has been a Clinical Microbiologist, providing support for infection control and antimicrobial stewardship services at various hospitals.
Associate Professor Harris has collaborated on many research projects with the Department of Infectious Diseases at Barwon Health and worked on Q fever outbreak investigations. He is involved in undergraduate and postgraduate teaching including supervision of infectious diseases/ microbiology registrar training with Barwon Health. In 2015, Associate Professor Harris was appointed Senior Clinical Lecturer and Clinical Associate Professor at Deakin University.
Dr Jenner began training in Chemical Pathology in 2001 and obtained the Fellowship from the Colleges of Medicine of South Africa in 2004 and a Master’s degree in Chemical Pathology from the University of Pretoria in 2005. He has worked as a senior registrar in Clinical Biochemistry at the Royal Infirmary of Edinburgh, as a consultant clinical biochemist at the NHS Borders Hospital (Scotland) and as a consultant chemical pathologist in private practice in South Africa.
In 2012 Dr Jenner relocated to Australia and worked as a senior registrar at the Royal Brisbane and Women’s Hospital. He obtained his Fellowship from the Royal College of Pathologists of Australasia in 2013 and joined Australian Clinical Labs in early 2014.
Due to an increase in demand for asymptomatic testing across Australia, Clinical Labs is pleased to offer tailored packages for organisations seeking to test their staff for COVID-19.
During the COVID-19 pandemic, temporary changes to the recommended process of diagnostic testing for GDM during pregnancy and for postnatal testing in women who have had GDM may be required. Local health care institutions should make the decision about the appropriate GDM testing protocol for their local population based on demographic factors and local public health data regarding the risk of COVID-19 exposure.
Information for doctors on Telehealth Consultations including our electronic pathology request form
For up-to-date information on patients presenting with symptoms of COVID-19 please see the below links for your relevant state.